On June 3, 2024, the board of directors of Fate Therapeutics, Inc. appointed J. Scott Wolchko, the Company?s President and Chief Executive Officer as the Company?s principal financial and accounting officer, effective immediately.  Mr. Wolchko previously served as the Chief Financial Officer of the Company from the commencement of its operations until August 2020.